Stay updated on Ribociclib and Trametinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Ribociclib and Trametinib in Solid Tumors Clinical Trial page.

Latest updates to the Ribociclib and Trametinib in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.4.1 and removed the prior funding-status notice (Revision: v3.4.0), indicating a routine site update.SummaryDifference0.4%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a glossary display and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The previous QC label wording ('Last Update Submitted that met QC Criteria'), 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check23 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe study locations section was updated: new sites in Arkansas, California, Connecticut, Florida, Massachusetts, Texas, Victoria, Alberta, British Columbia, and Catalonia were added (revision v3.3.3) and corresponding locations were removed (revision v3.3.2).SummaryDifference1%

- Check74 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; there are no visible changes to the page content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page header, reflecting a minor site update. No core content or study details appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ribociclib and Trametinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ribociclib and Trametinib in Solid Tumors Clinical Trial page.